Benzydamine plays a role in limiting inflammatory pain induced by neuronal sensitization.

Abstract

Benzydamine is an active pharmaceutical compound used in the oral care pharmaceutical preparation as NSAID. Beside from its anti-inflammatory action, benzydamine local application effectively reliefs pain showing analgesic and anaesthetic properties. Benzydamine mechanism of action has been characterized on inflammatory cell types and mediators highlighting its capacity to inhibit pro-inflammatory mediators' synthesis and release. On the other hand, the role of benzydamine as neuronal excitability modulator has not yet fully explored. Thus, we studied benzydamine's effect over primary cultured DRG nociceptors excitability and after acute and chronic inflammatory sensitization, as a model to evaluate relative nociceptive response. Benzydamine demonstrated to effectively inhibit neuronal basal excitability reducing its firing frequency and increasing rheobase and afterhyperpolarization amplitude. Its effect was time and dose-dependent. At higher doses, benzydamine induced changes in action potential wavelength, decreasing its height and slightly increasing its duration. Moreover, the compound reduced neuronal acute and chronic inflammatory sensitization. It inhibited neuronal excitability mediated either by an inflammatory cocktail, acidic pH or high external KCl. Notably, higher potency was evidenced under inflammatory sensitized conditions. This effect could be explained either by modulation of inflammatory and/or neuronal sensitizing signalling cascades or by direct modulation of proalgesic and action potential firing initiating ion channels. Apparently, the compound inhibited Nav1.8 channel but had no effect over Kv7.2, Kv7.3, TRPV1 and TRPA1. In conclusion, the obtained results strengthen the analgesic and anti-inflammatory effect of benzydamine, highlighting its mode of action on local pain and inflammatory signalling.

• Authors: Magdalena Nikolaeva-Koleva, Ana Espinosa, Matteo Vergassola, Lorenzo Polenzani, Giorgina Mangano, Lorella Ragni, Sara Zucchi, Antonio Ferrer-Montiel, Isabel Devesa
• Journal: Molecular pain (Mol Pain) 2023 Jan-Dec Vol. 19 Pg. 17448069231204191 ISSN: 1744-8069 [Electronic] United States
• PMID: 37710969 (Publication Type: Journal Article)

Chemical References

• Benzydamine
• Anti-Inflammatory Agents
• Analgesics

Topics

• Humans
• Benzydamine (metabolism, pharmacology, therapeutic use)
• Pain (drug therapy, metabolism)
• Nociceptors (metabolism)
• Inflammation (drug therapy, metabolism)
• Anti-Inflammatory Agents (therapeutic use)
• Analgesics (pharmacology, therapeutic use, metabolism)